Heron (Shanghai) Pharmaceutical Science and Technology Co., Ltd.

Alfacalcidol, a vitamin D3 analog, promotes active intestinal absorption of calcium and phosphate, enhances bone mineralization[1].

Alfacalcidol is indicated for the treatment of osteoporosis, chronic renal failure, hypoparathyroidism, vitamin D-resistant rickets and osteomalacia.
Recommended dosage: 0.25 to 0.5 μg once daily.

This product from Heron Pharma complies with USP, EP and ChP.

Reference：
[1] Schacht E, Richy F, Reginster JY. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures. J Musculoskelet Neuronal Interact. 2005;5(3):273-284.